메뉴 건너뛰기




Volumn 28, Issue 6, 2013, Pages 322-329

Aripiprazole augmentation for treatment of patients with chronic or recurrent major depressive disorder: A 12-week prospective open-label multicentre study

Author keywords

Antidepressant; Aripiprazole; Augmentation; Chronic depression; Recurrent depression

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; PROPRANOLOL; SERTRALINE; TIANEPTINE; VENLAFAXINE; ZOLPIDEM;

EID: 84885301928     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0b013e3283643728     Document Type: Review
Times cited : (14)

References (47)
  • 1
    • 0034030898 scopus 로고    scopus 로고
    • Practice guideline for the treatment of patients with major depressive disorder (revision
    • American Psychiatric Association. American Psychiatric Association
    • American Psychiatric Association (2000). Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. Am J Psychiatry 157:1-45
    • (2000) Am J Psychiatry , vol.157 , pp. 1-45
  • 3
    • 0031960136 scopus 로고    scopus 로고
    • SSRIS versus tricyclic antidepressants in depressed inpatients: A meta-Analysis of efficacy and tolerability
    • Anderson IM (1998). SSRIS versus tricyclic antidepressants in depressed inpatients: A meta-Analysis of efficacy and tolerability. Depress Anxiety 7 (Suppl 1):11-17
    • (1998) Depress Anxiety , vol.7 , Issue.SUPPL. 1 , pp. 11-17
    • Anderson, I.M.1
  • 4
    • 45349107889 scopus 로고    scopus 로고
    • Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 british association for psychopharmacology guidelines
    • Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, et al. (2008). Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 22:343-396
    • (2008) J Psychopharmacol , vol.22 , pp. 343-396
    • Anderson, I.M.1    Ferrier, I.N.2    Baldwin, R.C.3    Cowen, P.J.4    Howard, L.5    Lewis, G.6
  • 5
    • 0036047459 scopus 로고    scopus 로고
    • World federation of societies of biological psychiatry (wfsbp) guidelines for biological treatment of unipolar depressive disorders, part 1: Acute and continuation treatment of major depressive disorder
    • Bauer M, Whybrow PC, Angst J, Versiani M, Moller HJ (2002). World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 3:5-43
    • (2002) World J Biol Psychiatry , vol.3 , pp. 5-43
    • Bauer, M.1    Whybrow, P.C.2    Angst, J.3    Versiani, M.4    Moller, H.J.5
  • 6
    • 34347335477 scopus 로고    scopus 로고
    • The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study
    • Berman RM, Marcus RN, Swanink R, McQuade RD, Carson WH, Corey-Lisle PK, et al. (2007). The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychiatry 68:843-853
    • (2007) J Clin Psychiatry , vol.68 , pp. 843-853
    • Berman, R.M.1    Marcus, R.N.2    Swanink, R.3    McQuade, R.D.4    Carson, W.H.5    Corey-Lisle, P.K.6
  • 7
    • 66849141289 scopus 로고    scopus 로고
    • Aripiprazole augmentation in major depressive disorder: A doubleblind, placebo-controlled study in patients with inadequate response to antidepressants
    • Berman RM, Fava M, Thase ME, Trivedi MH, Swanink R, McQuade RD, et al. (2009). Aripiprazole augmentation in major depressive disorder: A doubleblind, placebo-controlled study in patients with inadequate response to antidepressants. CNS Spectr 14:197-206
    • (2009) CNS Spectr , vol.14 , pp. 197-206
    • Berman, R.M.1    Fava, M.2    Thase, M.E.3    Trivedi, M.H.4    Swanink, R.5    McQuade, R.D.6
  • 8
    • 0031439716 scopus 로고    scopus 로고
    • Clinical evaluation and plasma clozapine concentrations in Chinese patients with schizophrenia
    • Chong SA, Tan CH, Khoo YM, Lee HS, Wong KE, Ngui F, et al. (1997). Clinical evaluation and plasma clozapine concentrations in Chinese patients with schizophrenia. Ther Drug Monit 19:219-223
    • (1997) Ther Drug Monit , vol.19 , pp. 219-223
    • Chong, S.A.1    Tan, C.H.2    Khoo, Y.M.3    Lee, H.S.4    Wong, K.E.5    Ngui, F.6
  • 10
    • 60849086169 scopus 로고    scopus 로고
    • Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-Treatments meta-Analysis
    • Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. (2009). Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-Treatments meta-Analysis. Lancet 373:746-758
    • (2009) Lancet , vol.373 , pp. 746-758
    • Cipriani, A.1    Furukawa, T.A.2    Salanti, G.3    Geddes, J.R.4    Higgins, J.P.5    Churchill, R.6
  • 11
    • 1542726349 scopus 로고    scopus 로고
    • Sensitivity, specificity and predictive value of the echocardiography and troponin-T test combination in patients with non-ST elevation acute coronary syndromes
    • Di Pasquale P, Cannizzaro S, Scalzo S, Maringhini G, Sarullo FM, Cacia A, et al. (2004). Sensitivity, specificity and predictive value of the echocardiography and troponin-T test combination in patients with non-ST elevation acute coronary syndromes. Int J Cardiovasc Imaging 20:37-46
    • (2004) Int J Cardiovasc Imaging , vol.20 , pp. 37-46
    • Di Pasquale, P.1    Cannizzaro, S.2    Scalzo, S.3    Maringhini, G.4    Sarullo, F.M.5    Cacia, A.6
  • 12
    • 0037986382 scopus 로고    scopus 로고
    • Background and rationale for the sequenced treatment alternatives to relieve depression. STAR&z.ast;D) study
    • x
    • Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, et al. (2003). Background and rationale for the sequenced treatment alternatives to relieve depression (STAR&z.ast;D) study. Psychiatr Clin North Am 26:457-494, x.
    • (2003) Psychiatr Clin North Am , vol.26 , pp. 457-494
    • Fava, M.1    Rush, A.J.2    Trivedi, M.H.3    Nierenberg, A.A.4    Thase, M.E.5    Sackeim, H.A.6
  • 14
    • 84873406549 scopus 로고    scopus 로고
    • Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder. 2006 2010
    • Jing Y, Guo Z, Kalsekar I, Forbes RA, Hebden T, Thase ME (2013). Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006-2010). Int Clin Psychopharmacol 28:87-90
    • (2013) Int Clin Psychopharmacol , vol.28 , pp. 87-90
    • Jing, Y.1    Guo, Z.2    Kalsekar, I.3    Forbes, R.A.4    Hebden, T.5    Thase, M.E.6
  • 16
    • 0034953106 scopus 로고    scopus 로고
    • Clinical guidelines for the treatment of depressive disorders iv medications and other biological treatments
    • Kennedy SH, Lam RW, Cohen NL, Ravindran AV (2001). Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Can J Psychiatry 46 (Suppl 1):38S-58S.
    • (2001) Can J Psychiatry , vol.46 , Issue.SUPPL. 1
    • Kennedy, S.H.1    Lam, R.W.2    Cohen, N.L.3    Ravindran, A.V.4
  • 17
    • 0037831023 scopus 로고    scopus 로고
    • The epidemiology of major depressive disorder: Results from the national comorbidity survey replication (ncs-r
    • Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. (2003). The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:3095-3105
    • (2003) JAMA , vol.289 , pp. 3095-3105
    • Kessler, R.C.1    Berglund, P.2    Demler, O.3    Jin, R.4    Koretz, D.5    Merikangas, K.R.6
  • 18
    • 0346098317 scopus 로고    scopus 로고
    • Prevalence of chronic pain and its impact on health-related quality of life in stroke survivors
    • Kong KH, Woon VC, Yang SY (2004). Prevalence of chronic pain and its impact on health-related quality of life in stroke survivors. Arch Phys Med Rehabil 85:35-40
    • (2004) Arch Phys Med Rehabil , vol.85 , pp. 35-40
    • Kong, K.H.1    Woon, V.C.2    Yang, S.Y.3
  • 19
  • 20
    • 40949089056 scopus 로고    scopus 로고
    • The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A second multicenter, randomized, double-blind, placebo-controlled study
    • Marcus RN, McQuade RD, Carson WH, Hennicken D, Fava M, Simon JS, et al. (2008). The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 28:156-165
    • (2008) J Clin Psychopharmacol , vol.28 , pp. 156-165
    • Marcus, R.N.1    McQuade, R.D.2    Carson, W.H.3    Hennicken, D.4    Fava, M.5    Simon, J.S.6
  • 21
    • 17744372691 scopus 로고    scopus 로고
    • A population study on differences in the determinants of a specific shoulder disorder versus nonspecific shoulder pain without clinical findings
    • Miranda H, Viikari-Juntura E, Heistaro S, Heliovaara M, Riihimaki H (2005). A population study on differences in the determinants of a specific shoulder disorder versus nonspecific shoulder pain without clinical findings. Am J Epidemiol 161:847-855
    • (2005) Am J Epidemiol , vol.161 , pp. 847-855
    • Miranda, H.1    Viikari-Juntura, E.2    Heistaro, S.3    Heliovaara, M.4    Riihimaki, H.5
  • 22
    • 2342454373 scopus 로고    scopus 로고
    • Buprenorphinesoaked absorbable gelatin sponge: An alternative method for postlaminectomy pain relief
    • Mishra LD, Nath SS, Gairola RL, Verma RK, Mohanty S (2004). Buprenorphinesoaked absorbable gelatin sponge: An alternative method for postlaminectomy pain relief. J Neurosurg Anesthesiol 16:115-121
    • (2004) J Neurosurg Anesthesiol , vol.16 , pp. 115-121
    • Mishra, L.D.1    Nath, S.S.2    Gairola, R.L.3    Verma, R.K.4    Mohanty, S.5
  • 23
    • 0029907597 scopus 로고    scopus 로고
    • Evidence-based health policy -lessons from the global burden of disease study
    • Murray CJ, Lopez AD (1996a). Evidence-based health policy -lessons from the Global Burden of Disease Study. Science 274:740-743
    • (1996) Science , vol.274 , pp. 740-743
    • Murray, C.J.1    Lopez, A.D.2
  • 25
    • 29344438594 scopus 로고    scopus 로고
    • Use of atypical antipsychotics in refractory depression and anxiety
    • Nemeroff CB (2005). Use of atypical antipsychotics in refractory depression and anxiety. J Clin Psychiatry 66 (Suppl 8):13-21
    • (2005) J Clin Psychiatry , vol.66 , Issue.SUPPL. 8 , pp. 13-21
    • Nemeroff, C.B.1
  • 26
    • 1642566659 scopus 로고    scopus 로고
    • Comorbidities in chronic neuropathic pain
    • Nicholson B, Verma S (2004). Comorbidities in chronic neuropathic pain. Pain Med 5 (Suppl 1):S9-S27
    • (2004) Pain Med , vol.5 , Issue.SUPPL. 1
    • Nicholson, B.1    Verma, S.2
  • 27
    • 3142760860 scopus 로고    scopus 로고
    • Anxiety and depression among the epileptics in general population in benin (western africa
    • Nubukpo P, Houinato D, Preux PM, Avode G, Clement JP (2004). Anxiety and depression among the epileptics in general population in Benin (Western Africa). Encephale 30:214-219
    • (2004) Encephale , vol.30 , pp. 214-219
    • Nubukpo, P.1    Houinato, D.2    Preux, P.M.3    Avode, G.4    Clement, J.P.5
  • 28
    • 77954620749 scopus 로고    scopus 로고
    • Comments On 'aripiprazole in major depression and mania: Meta-Analyses of randomized placebo-controlled trials
    • author reply 449
    • Pae CU (2010). Comments on 'aripiprazole in major depression and mania: Meta-Analyses of randomized placebo-controlled trials'. Gen Hosp Psychiatry 32:448; author reply 449
    • (2010) Gen Hosp Psychiatry , vol.32 , pp. 448
    • Pae, C.U.1
  • 29
    • 36049036898 scopus 로고    scopus 로고
    • Aripiprazole augmentation for treatment of patients with inadequate antidepressants response
    • Pae CU, Patkar AA, Jun TY, Lee C, Masand PS, Paik IH (2007). Aripiprazole augmentation for treatment of patients with inadequate antidepressants response. Depress Anxiety 24:522-526
    • (2007) Depress Anxiety , vol.24 , pp. 522-526
    • Pae, C.U.1    Patkar, A.A.2    Jun, T.Y.3    Lee, C.4    Masand, P.S.5    Paik, I.H.6
  • 30
    • 41949107744 scopus 로고    scopus 로고
    • Aripiprazole in the treatment of depressive and anxiety disorders: A review of current evidence
    • Pae CU, Serretti A, Patkar AA, Masand PS (2008). Aripiprazole in the treatment of depressive and anxiety disorders: A review of current evidence. CNS Drugs 22:367-388
    • (2008) CNS Drugs , vol.22 , pp. 367-388
    • Pae, C.U.1    Serretti, A.2    Patkar, A.A.3    Masand, P.S.4
  • 32
    • 78951471427 scopus 로고    scopus 로고
    • Aripiprazole as adjunctive therapy for patients with major depressive disorder: Overview and implications of clinical trial data
    • Pae CU, Forbes A, Patkar AA (2011). Aripiprazole as adjunctive therapy for patients with major depressive disorder: Overview and implications of clinical trial data. CNS Drugs 25:109-127
    • (2011) CNS Drugs , vol.25 , pp. 109-127
    • Pae, C.U.1    Forbes, A.2    Patkar, A.A.3
  • 33
    • 27544477735 scopus 로고    scopus 로고
    • Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder
    • Papakostas GI, Petersen TJ, Kinrys G, Burns AM, Worthington JJ, Alpert JE, et al. (2005). Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder. J Clin Psychiatry 66: 1326-1330
    • (2005) J Clin Psychiatry , vol.66 , pp. 1326-1330
    • Papakostas, G.I.1    Petersen, T.J.2    Kinrys, G.3    Burns, A.M.4    Worthington, J.J.5    Alpert, J.E.6
  • 34
    • 34948830502 scopus 로고    scopus 로고
    • Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-Analysis of studies of newer agents
    • Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC (2007). Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-Analysis of studies of newer agents. Biol Psychiatry 62:1217-1227
    • (2007) Biol Psychiatry , vol.62 , pp. 1217-1227
    • Papakostas, G.I.1    Thase, M.E.2    Fava, M.3    Nelson, J.C.4    Shelton, R.C.5
  • 36
    • 1942505283 scopus 로고    scopus 로고
    • Special issues in the management of depression in older patients
    • Rabheru K (2004). Special issues in the management of depression in older patients. Can J Psychiatry 49:41S-50S.
    • (2004) Can J Psychiatry , vol.49
    • Rabheru, K.1
  • 37
    • 33751338530 scopus 로고    scopus 로고
    • Acute and longer-Term outcomes in depressed outpatients requiring one or several treatment steps: A STAR&z.ast;D report
    • Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. (2006). Acute and longer-Term outcomes in depressed outpatients requiring one or several treatment steps: A STAR&z.ast;D report. Am J Psychiatry 163:1905-1917
    • (2006) Am J Psychiatry , vol.163 , pp. 1905-1917
    • Rush, A.J.1    Trivedi, M.H.2    Wisniewski, S.R.3    Nierenberg, A.A.4    Stewart, J.W.5    Warden, D.6
  • 39
    • 1542268226 scopus 로고    scopus 로고
    • Psychological aspects of fibromyalgia: Research vs. Clinician impressions
    • Sansone RA, Levengood JV, Sellbom M (2004). Psychological aspects of fibromyalgia: Research vs. clinician impressions. J Psychosom Res 56:185-188
    • (2004) J Psychosom Res , vol.56 , pp. 185-188
    • Sansone, R.A.1    Levengood, J.V.2    Sellbom, M.3
  • 41
    • 34547165040 scopus 로고    scopus 로고
    • Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17
    • Shen H, He MM, Liu H, Wrighton SA, Wang L, Guo B, et al. (2007). Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17. Drug Metab Dispos 35:1292-1300
    • (2007) Drug Metab Dispos , vol.35 , pp. 1292-1300
    • Shen, H.1    He, M.M.2    Liu, H.3    Wrighton, S.A.4    Wang, L.5    Guo, B.6
  • 42
    • 27544485778 scopus 로고    scopus 로고
    • Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder
    • Simon JS, Nemeroff CB (2005). Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder. J Clin Psychiatry 66:1216-1220
    • (2005) J Clin Psychiatry , vol.66 , pp. 1216-1220
    • Simon, J.S.1    Nemeroff, C.B.2
  • 43
    • 17844392667 scopus 로고    scopus 로고
    • Altered function of the hypothalamic-pituitary-Adrenal axis in patients with acute, chronic and episodic pain
    • Strittmatter M, Bianchi O, Ostertag D, Grauer M, Paulus C, Fischer C, et al. (2005). Altered function of the hypothalamic-pituitary-Adrenal axis in patients with acute, chronic and episodic pain. Schmerz 19:109-116
    • (2005) Schmerz , vol.19 , pp. 109-116
    • Strittmatter, M.1    Bianchi, O.2    Ostertag, D.3    Grauer, M.4    Paulus, C.5    Fischer, C.6
  • 44
    • 3042829186 scopus 로고    scopus 로고
    • Assessment of self-reported physical activity in patients with chronic pain: Development of an abbreviated Roland-Morris disability scale
    • Stroud MW, McKnight PE, Jensen MP (2004). Assessment of self-reported physical activity in patients with chronic pain: Development of an abbreviated Roland-Morris disability scale. J Pain 5:257-263
    • (2004) J Pain , vol.5 , pp. 257-263
    • Stroud, M.W.1    McKnight, P.E.2    Jensen, M.P.3
  • 45
    • 44849092681 scopus 로고    scopus 로고
    • Omega-3 fatty acids for major depressive disorder during pregnancy: Results from a randomized, double-blind, placebo-controlled trial
    • Su KP, Huang SY, Chiu TH, Huang KC, Huang CL, Chang HC, et al. (2008). Omega-3 fatty acids for major depressive disorder during pregnancy: Results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 69:644-651
    • (2008) J Clin Psychiatry , vol.69 , pp. 644-651
    • Su, K.P.1    Huang, S.Y.2    Chiu, T.H.3    Huang, K.C.4    Huang, C.L.5    Chang, H.C.6
  • 46
    • 30044433660 scopus 로고    scopus 로고
    • Evaluation of outcomes with citalopram for depression using measurement-based care in STAR&z.ast;D: Implications for clinical practice
    • Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR&z.ast;D: Implications for clinical practice. Am J Psychiatry 163:28-40
    • (2006) Am J Psychiatry , vol.163 , pp. 28-40
    • Trivedi, M.H.1    Rush, A.J.2    Wisniewski, S.R.3    Nierenberg, A.A.4    Warden, D.5    Ritz, L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.